Release 5

This page is part of the FHIR Specification (v5.0.0: R5 - STU). This is the current published version. For a full list of available versions, see the Directory of published versions . Page versions: R5 R4B

Example ClinicalUseDefinition/example (Narrative)

Biomedical Research and Regulation Work GroupMaturity Level: N/AStandards Status: InformativeCompartments: No defined compartments

This is the narrative for the resource. See also the XML, JSON or Turtle format. This example conforms to the profile ClinicalUseDefinition.


Generated Narrative: ClinicalUseDefinition

Resource ClinicalUseDefinition "example"

type: contraindication

contraindication

DiseaseSymptomProcedures

-Concept
*Hepatic disease associated with coagulopathy and clinically relevant bleeding risk (contraindicationsasdisease-symptom-procedure#Coagulopathiesandbleedingdiatheses(exclthrombocytopenic))

Comorbidities

-Concept
*Hepaticdisease (comorbidity#Hepaticdisease)

 

 

Usage note: every effort has been made to ensure that the examples are correct and useful, but they are not a normative part of the specification.